Calif. heart device firm completes $48 million funding round

03/1/2013 | American City Business Journals

CardioKinetix has raised $23 million in the second tranche of its Series E funding round, bringing the total for that round to $48 million. The funding will enable the company to advance its efforts to bring its Parachute ventricular partitioning system designed for heart failure patients to the global market, President and CEO Maria Sainz said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA